牛叉诊股

同花顺高级诊股公告

同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！

同花顺特色产品: 〈高级诊股〉 全方位深度分析，提供明确投资建议

君实生物（688180）

4.8

综合诊断：4.8分打败了65%的股票！

卖出
减持
中性
增持
买入

短期趋势：
前期的强势行情已经结束，投资者及时卖出股票为为宜。
中期趋势：
有加速下跌的趋势。
长期趋势：
已有384家主力机构披露2025-12-31报告期持股数据，持仓量总计2.24亿股，占流通A股29.18%
波段诊断：
-
历史波段诊断>>

高级诊股策略资深顾问建议

分享到：

加自选 向专家提问

技术面诊股资金面诊股消息面诊股行业面诊股基本面诊股

3.9分

3.6分

5.5分

2.0分

7.4分

风险提示：诊断结果通过运算模型加工客观数据而成，仅供参考，不构成绝对投资建议。

技术面诊股

诊断结果：3.9技术面打败了50%的股票技术面评分前10的股票

近期的平均成本为30.21元。空头行情中，并且有加速下跌的趋势。

技术面得分最高的股票

平均成本

近期的平均成本为30.21元。

[{"text":"\u5e73\u5747\u6210\u672c","value":"30.21","date":1782377924,"color":"0x9f0ba1"}]

市场表现

过去10个交易日，该股走势接近大盘，跑赢行业平均水平。

[{"date":"2026.06.26","stock":"-5.27","trade":"-3.87","ind":"-2.26"},{"date":"2026.06.25","stock":"-0.13","trade":"-1.00","ind":"0.23"},{"date":"2026.06.24","stock":"3.09","trade":"-1.03","ind":"0.11"},{"date":"2026.06.23","stock":"0.93","trade":"2.96","ind":"-1.37"},{"date":"2026.06.22","stock":"0.20","trade":"-0.76","ind":"1.78"},{"date":"2026.06.18","stock":"2.38","trade":"1.76","ind":"-0.43"},{"date":"2026.06.17","stock":"-1.31","trade":"-0.52","ind":"0.40"},{"date":"2026.06.16","stock":"-1.39","trade":"-0.68","ind":"-0.11"},{"date":"2026.06.15","stock":"-1.60","trade":"-0.31","ind":"1.61"},{"date":"2026.06.12","stock":"4.28","trade":"2.41","ind":"1.12"},{"date":"2026.06.11","stock":"-0.34","trade":"-1.14","ind":"-0.16"},{"date":"2026.06.10","stock":"0.82","trade":"-0.10","ind":"-0.42"},{"date":"2026.06.09","stock":"1.24","trade":"0.25","ind":"1.28"},{"date":"2026.06.08","stock":"-3.95","trade":"-2.98","ind":"-1.70"},{"date":"2026.06.05","stock":"-2.84","trade":"0.27","ind":"-0.74"},{"date":"2026.06.04","stock":"-2.82","trade":"-1.92","ind":"-0.64"},{"date":"2026.06.03","stock":"-0.90","trade":"-1.41","ind":"0.22"},{"date":"2026.06.02","stock":"-2.54","trade":"-1.97","ind":"0.43"},{"date":"2026.06.01","stock":"-3.53","trade":"-0.39","ind":"-0.27"},{"date":"2026.05.29","stock":"2.18","trade":"0.05","ind":"-0.73"},{"date":"2026.05.28","stock":"-2.45","trade":"-0.93","ind":"0.12"}]

君实生物,上证指数,生物制品指数

压力支撑

该股压力位为30.43元，支撑位为29.05元。

[{"text":"\u538b\u529b\u4f4d","value":"30.43","date":1782403200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"29.05","date":1782403200,"color":"0x0b52a1"}]

多空趋势

空头行情中，并且有加速下跌的趋势。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：3.6资金面打败了49%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力集中了一定的筹码，呈中度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

生物制品行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：06月26日 20:31

机构今日流向(万元)	-3008.90	机构5日流向(万元)	-4225.60
机构10日流向(万元)	-4470.49	机构20日流向(万元)	-12577.61

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量减少4800.82万股，其中基金净减仓73家，主力净增仓21家，暂未发现中长期投资价值。

截止2025-12-31，共384家主力机构（基金382家，一般法人2家），持仓量总计22366.39万股，占流通A股29.18%
其中，基金持仓与2025-06-30相比：
增仓：75家，增持 948.45万股
减仓：148家，减持 2006.05万股
新出现在主力名单中：150家，持有901.09万股
从主力名单中消失：129家，原持有3444.31万股

消息面诊股

诊断结果：5.5消息面打败了76%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	股东大会	年度股东大会	2026-06-06
一般消息	募资投向		2026-06-06
一般消息	募资投向	公司出售资产	2026-06-06
一般消息	募资投向	公司购买资产	2026-06-06
一般消息	重大事项	关联交易	2026-06-06
一般消息	高管变动	其他工作安排	2026-06-05
一般消息	高管变动	因个人原因	2026-03-14
一般消息	分红转增	不分配不转增	2026-03-14
一般消息	高管变动	委员会调整	2026-03-13
利好	业绩预告	预计减亏	2026-01-31
利好	重大事项	参股拟上市公司或非上市公司金融机构	2025-12-31
一般消息	重大事项	关联交易	2025-09-30
一般消息	高管变动	取消监事会	2025-09-29
一般消息	分红转增	不分配不转增	2025-08-27
利好	重大事项	参股拟上市公司或非上市公司金融机构	2025-06-30

一年消息统计

	所有消息	重大消息	非重大消息
利好	3条	0条	3条
利空	0条	0条	0条

行业面诊股

诊断结果：2.0行业面打败了34%的股票生物制品行业最新资金流向

近10日来该行业走势不明显，明显跑输大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，明显跑输大盘。

[{"date":"2026.06.26","price":"-2.26","value":"-3.87"},{"date":"2026.06.25","price":"0.23","value":"-1.00"},{"date":"2026.06.24","price":"0.11","value":"-1.03"},{"date":"2026.06.23","price":"-1.37","value":"2.96"},{"date":"2026.06.22","price":"1.78","value":"-0.76"},{"date":"2026.06.18","price":"-0.43","value":"1.76"},{"date":"2026.06.17","price":"0.40","value":"-0.52"},{"date":"2026.06.16","price":"-0.11","value":"-0.68"},{"date":"2026.06.15","price":"1.61","value":"-0.31"},{"date":"2026.06.12","price":"1.12","value":"2.41"},{"date":"2026.06.11","price":"-0.16","value":"-1.14"},{"date":"2026.06.10","price":"-0.42","value":"-0.10"},{"date":"2026.06.09","price":"1.28","value":"0.25"},{"date":"2026.06.08","price":"-1.70","value":"-2.98"},{"date":"2026.06.05","price":"-0.74","value":"0.27"},{"date":"2026.06.04","price":"-0.64","value":"-1.92"},{"date":"2026.06.03","price":"0.22","value":"-1.41"},{"date":"2026.06.02","price":"0.43","value":"-1.97"},{"date":"2026.06.01","price":"-0.27","value":"-0.39"},{"date":"2026.05.29","price":"-0.73","value":"0.05"},{"date":"2026.05.28","price":"0.12","value":"-0.93"}]

上证指数,生物制品行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	赛伦生物	18.96%	-8.78%	5.5分
2	百普赛斯	8.03%	8.24%	5.4分
3	东宝生物	5.60%	-3.47%	4.9分
4	欧林生物	4.16%	7.23%	6.0分
5	诺唯赞	3.91%	-2.04%	5.4分
6	荣昌生物	3.71%	-1.30%	5.2分
7	诺诚健华	3.48%	6.04%	5.3分
8	甘李药业	3.30%	-5.17%	4.8分
9	三生国健	2.17%	3.26%	5.3分
10	-	0.00%	-10.58%	分
11	昊帆生物	-1.56%	6.13%	4.8分
12	赛升药业	-2.52%	4.42%	5.0分
13	康弘药业	-3.18%	-1.51%	4.6分
14	我武生物	-3.75%	0.24%	4.4分
15	特宝生物	-3.89%	-5.18%	5.4分
16	义翘神州	-3.91%	0.08%	4.5分
17	通化东宝	-5.23%	-0.40%	4.7分
18	华兰生物	-5.46%	-5.61%	4.0分
19	西藏药业	-5.75%	-3.26%	4.9分
20	安科生物	-5.90%	-2.22%	5.2分
21	-	-6.29%	-1.45%	分
22	辽宁成大	-6.61%	-0.59%	4.8分
23	华兰疫苗	-6.71%	-3.76%	4.8分
24	康华生物	-7.29%	-5.59%	3.8分
25	博雅生物	-7.80%	-9.50%	4.6分
26	优宁维	-8.90%	-1.27%	4.5分
27	成大生物	-9.85%	-4.25%	4.5分
28	沃森生物	-11.39%	-5.28%	4.7分
29	君实生物	-11.43%	-1.36%	4.8分
30	科兴制药	-11.47%	-1.26%	4.4分
31	四环生物	-12.36%	0.00%	5.2分
32	康泰生物	-12.59%	-4.77%	4.0分
33	天坛生物	-12.70%	-7.31%	4.0分
34	百克生物	-13.56%	-4.57%	4.8分
35	神州细胞	-13.79%	-3.40%	4.8分
36	长春高新	-13.97%	-2.03%	4.3分
37	百奥泰	-15.40%	-5.63%	4.4分
38	迈威生物	-15.59%	-5.84%	4.5分
39	上海莱士	-16.31%	-6.71%	3.7分
40	博晖创新	-16.73%	-6.07%	4.2分
41	智飞生物	-16.99%	-6.80%	3.7分
42	康希诺	-17.29%	-4.07%	4.0分
43	禾元生物	-18.47%	-6.99%	4.7分
44	康辰药业	-19.63%	-4.55%	4.6分
45	卫光生物	-19.82%	-9.74%	3.9分
46	金迪克	-20.05%	-4.20%	4.3分
47	双成药业	-20.69%	-5.05%	4.6分
48	近岸蛋白	-23.48%	-6.42%	4.6分
49	艾迪药业	-23.75%	-7.80%	4.4分
50	万泽股份	-23.89%	-15.33%	4.5分
51	*ST未名	-25.23%	-18.58%	4.6分
52	智翔金泰	-27.38%	-1.92%	3.9分
53	派林生物	-29.79%	-18.04%	4.9分
54	-	-40.94%	-1.44%	分

<上一页 1 2 3 4 5...9 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：7.4基本面打败了95%的股票连续3年业绩增长30%的公司

该公司运营状况良好，多数机构认为该股长期投资价值较高。

个股深一度

潜在高分红能力：弱（27.5分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：很强，居行业前列，两项指标的行业排名分别为 37/70 ， 17/70。

[{"date":"2026-03-31","value":"-0.34","vol":"-2.96"},{"date":"2025-12-31","value":"-14.72","vol":"-8.40"},{"date":"2025-09-30","value":"-9.87","vol":"-10.09"},{"date":"2025-06-30","value":"-6.75","vol":"-0.67"},{"date":"2025-03-31","value":"-4.09","vol":"0.44"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	-0.34	-14.72	-9.87	-6.75	-4.09
行业(%)	-2.96	-8.40	-10.09	-0.67	0.44

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"79.76","vol":"61.64"},{"date":"2025-12-31","value":"81.33","vol":"66.98"},{"date":"2025-09-30","value":"80.65","vol":"67.71"},{"date":"2025-06-30","value":"80.06","vol":"67.98"},{"date":"2025-03-31","value":"81.24","vol":"69.02"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	79.76	81.33	80.65	80.06	81.24
行业(%)	61.64	66.98	67.71	67.98	69.02

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：很强，居行业前列，两项指标的行业排名分别为 6/70 ， 7/70。

[{"date":"2026-03-31","value":"45.09","vol":"16.15"},{"date":"2025-12-31","value":"28.23","vol":"35.93"},{"date":"2025-09-30","value":"42.06","vol":"45.81"},{"date":"2025-06-30","value":"48.64","vol":"7037.48"},{"date":"2025-03-31","value":"31.46","vol":"6245.21"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	45.09	28.23	42.06	48.64	31.46
行业(%)	16.15	35.93	45.81	7037.48	6245.21

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"91.24","vol":"74.78"},{"date":"2025-12-31","value":"31.68","vol":"34.78"},{"date":"2025-09-30","value":"35.72","vol":"45.67"},{"date":"2025-06-30","value":"36.01","vol":"5.32"},{"date":"2025-03-31","value":"17.01","vol":"-8.96"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	91.24	31.68	35.72	36.01	17.01
行业(%)	74.78	34.78	45.67	5.32	-8.96

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：尚可，接近行业平均，两项指标的行业排名分别为 26/70 ， 21/70。

[{"date":"2026-03-31","value":"0.05","vol":"0.06"},{"date":"2025-12-31","value":"0.22","vol":"0.30"},{"date":"2025-09-30","value":"0.16","vol":"0.21"},{"date":"2025-06-30","value":"0.10","vol":"0.14"},{"date":"2025-03-31","value":"0.05","vol":"0.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.05	0.22	0.16	0.10	0.05
行业(次)	0.06	0.30	0.21	0.14	0.06

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.26","vol":"0.29"},{"date":"2025-12-31","value":"0.81","vol":"1.30"},{"date":"2025-09-30","value":"0.64","vol":"0.90"},{"date":"2025-06-30","value":"0.41","vol":"0.56"},{"date":"2025-03-31","value":"0.16","vol":"0.26"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	0.26	0.81	0.64	0.41	0.16
行业(次)	0.29	1.30	0.90	0.56	0.26

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"7.97","vol":"-71.66"},{"date":"2025-12-31","value":"-25.44","vol":"12.85"},{"date":"2025-09-30","value":"-2.20","vol":"0.21"},{"date":"2025-06-30","value":"-45.68","vol":"-1404.66"},{"date":"2025-03-31","value":"-4.86","vol":"-47.97"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	7.97	-25.44	-2.20	-45.68	-4.86
行业	-71.66	12.85	0.21	-1404.66	-47.97

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"2.41","vol":"1.77"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.96","vol":"1.58"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	2.41	-	1.96	-
行业	0.00	1.77	0.00	1.58	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 1/70 ， 21/70。

[{"date":"2026-03-31","value":"2.14","vol":"6.75"},{"date":"2025-12-31","value":"1.60","vol":"5.88"},{"date":"2025-09-30","value":"1.62","vol":"6.07"},{"date":"2025-06-30","value":"1.61","vol":"6.70"},{"date":"2025-03-31","value":"1.40","vol":"7.82"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	2.14	1.60	1.62	1.61	1.40
行业	6.75	5.88	6.07	6.70	7.82

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"1.87","vol":"5.22"},{"date":"2025-12-31","value":"1.34","vol":"4.49"},{"date":"2025-09-30","value":"1.35","vol":"4.89"},{"date":"2025-06-30","value":"1.36","vol":"5.34"},{"date":"2025-03-31","value":"1.13","vol":"6.40"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	1.87	1.34	1.35	1.36	1.13
行业	5.22	4.49	4.89	5.34	6.40

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：一般，低于行业平均，两项指标的行业排名分别为 9/70 ， 6/70。

[{"date":"2026-03-31","value":"56.97","vol":"27.44"},{"date":"2025-12-31","value":"51.09","vol":"27.58"},{"date":"2025-09-30","value":"46.14","vol":"28.02"},{"date":"2025-06-30","value":"45.25","vol":"26.70"},{"date":"2025-03-31","value":"47.98","vol":"26.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	56.97	51.09	46.14	45.25	47.98
行业(%)	27.44	27.58	28.02	26.70	26.06

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"1.37","vol":"1.46"},{"date":"2025-12-31","value":"1.05","vol":"1.28"},{"date":"2025-09-30","value":"0.87","vol":"0.58"},{"date":"2025-06-30","value":"0.83","vol":"1.13"},{"date":"2025-03-31","value":"0.93","vol":"0.79"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	1.37	1.05	0.87	0.83	0.93
行业(%)	1.46	1.28	0.58	1.13	0.79

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
华西证券	2026-05-18	买入
国海证券	2026-05-17	增持
国金证券	2026-05-16	买入
开源证券	2026-05-14	买入
东北证券	2026-04-20	增持
天风证券	2026-04-15	买入

机构预测

机构预测该股2026年每股收益与前一年相同，长期投资价值一般。

[{"date":"2022","yellowRectValue":"-23.88","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-22.83","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-12.81","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-8.75","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"-3.88","blueLineValue":"-0.38","type":"YC"}]

[君实生物]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]